Log in or Register for enhanced features | Forgotten Password?
White Papers | Suppliers | Events | Report Store | Companies | Dining Club | Medical Devices | Videos
Pharmaceutical Business Review
Return to: PBR Home
Search Refinements
Search Results:
1-15 of 55632 results
US DOD to commence new trial with Pluristem's PLX-R18 cell therapy against ARS
Pluristem Therapeutics stated that a pilot study of its PLX-R18 cell therapy will be initiated by the US Department of Defense’s (DOD) Armed Forces Radiobiology Research Institute (AFRRI), part of the Uniformed Services University of Health Sciences (USU).
Contract Research & Services > Clinical Trials > News
Atreca raises $35m to advance novel cancer immunotherapies
Atreca, a privately held biotechnology company developing novel therapeutics drawn from human immune responses, has closed its Series B round of financing with an investment totaling $35m.
Drug Research > Drug Discovery & Development > News
Pfizer gets FDA nod for blood cancer treatment Besponsa
By PBR Staff Writer
Pfizer has secured approval from the US Food and Drug Administration (FDA) for its Besponsa (inotuzumab ozogamicin) to treat adults with relapsed or refractory B-cell precursor acute lymphoblastic leukemia (ALL).
Regulatory Affairs > News
NSF International Adds Pharma Biotech Services to India Office
NSF’s pharma biotech experts now serving India’s pharmaceutical industry from Gurugram office
Press Releases
GSK to evaluate Insilico’s AI technology to enhance drug discovery process.
By PBR Staff Writer
GlaxoSmithKline and Insilico Medicine are partnering to assess how the latter’s artificial intelligence (AI) technology can help in the drug discovery process.
Drug Research > Drug Discovery & Development > News
Evotec completes Aptuit acquisition
German company Evotec has completed the acquisition of US-based Aptuit.
Drug Research > Drug Discovery & Development > News
Seattle Genetics gets FDA priority review for Adcetris in Cutaneous T-Cell Lymphoma
Seattle Genetics reported that the US Food and Drug Administration (FDA) has accepted for filing a supplemental Biologics License Application (BLA) based on data from the phase 3 ALCANZA trial and two phase 2 trials of ADCETRIS (brentuximab vedotin) in patients with cutaneous T-cell lymphoma (CTCL).
Production & Manufacturing > Process & Production > News
Mateon’s ovarian cancer treatment CA4P shows favorable results in Focus study
By PBR Staff Writer
Mateon Therapeutics’ ovarian cancer treatment CA4P in combination with Roche’s bevacizumab (Avastin) has showed favorable results in the scheduled interim analysis of the ongoing phase 2/3 Focus study.
Contract Research & Services > Clinical Trials > News
Alvogen to acquire Russia-based Omega Bittner
Alvogen has agreed to acquire Omega Bittner, a Russia-based pharmaceutical firm owned by Perrigo Company.
News
Aradigm gets NIH grant for Linhaliq in pulmonary non-tuberculous mycobacteria treatment
The National Institute of Allergy and Infectious Diseases (NIAID) and National Institutes of Health (NIH) have awarded a Small Business Initiative Research (SBIR) grant to Aradigm to study the treatment of two pulmonary non-tuberculous mycobacteria (PNTM) infections, Mycobacterium avium and Mycobacterium abscessus, with the company’s inhaled liposomal ciprofloxacin products Linhaliq and Lipoquin.
Contract Research & Services > Clinical Trials > News
FDA lifts clinical hold on study of Multikine for head and neck cancer
By PBR Staff Writer
The US Food and Drug Administration (FDA) has lifted the clinical hold it had imposed on the CEL-SCI and Ergomed co-developed Multikine’s phase 3 head and neck cancer study.
Regulatory Affairs > News
BMS’ kidney cancer drug met co-primary endpoint in CheckMate trial
By PBR Staff Writer
Bristol-Myers Squibb’s (BMS) kidney cancer drug Opdivo in combination with Yervoy (ipilimumab) has met the co-primary endpoint of objective response rate (ORR) against sunitinib in CheckMate -214 trial.
Contract Research & Services > Clinical Trials > News
H3 Biomedicine gets FDAorphan drug status for acute myelogenous leukemia treatment
The US Food and Drug Administration (FDA) has granted orphan drug designation for H3 Biomedicine's H3B-8800, its lead clinical compound for the treatment of patients with Acute Myelogenous Leukemia (AML) and Chronic Myelomonocytic Leukemia (CMML).
Production & Manufacturing > Process & Production > News
Vicarius Pharma secures $21.8m financing
Vicarius Pharma has secured a CHF21m ($21.8m) investment through a Series A preferred stock financing from private investors.
Drug Research > Drug Discovery & Development > News
Ophthotech’s wet-AMD drug Fovista fails in phase 3 AMD trial
By PBR Staff Writer
Ophthotech’s anti-PDGF therapy Fovista (pegpleranib) for treating wet age-related macular degeneration (AMD) has failed to meet the primary endpoint in a phase 3 trial.
Contract Research & Services > Clinical Trials > News

PBR Supplier Recommendations

Vetter Pharma International - High-Quality Aseptically Pre-Filled Injection Systems
From preclinical development through commercial supply.... Drug Research > Drug Delivery > Suppliers
Patient Focused Medicines Development (PFMD)
Patients Focused Medicine Development (PFMD) is an open, global and collaborative coalition of patient organisations and advocates, pharma and life sciences industry, HTA bodies, national advisory organisations and regulators. Their aim is to drive meaningful patient engagement by co-creating a standardised and globally adopted framework for patient engagement, so that patients' needs and priorities are at the core of medicines development and lifecycle. PFMD was established in 2015 and currently counts 24 members. Their 'Pledge to Patients' campaign encourages members of the medical community to commit to measurable actions to improve patient engagement.... Drug Research > Drug Delivery > Suppliers
Haselmeier - Self-Injection Devices
Haselmeier is a leading developer and manufacturer of innovative self-injection devices featuring proprietary designs, technology and intellectual property. With over four decades of medical device experience, Haselmeier has built up a world class Design and Development Team – working in compliance with regulatory requirements – for the creation, design and industrialization of our innovative self-injection systems used by pharmaceutical and biotechnology companies worldwide. ... Suppliers
CTL Laboratories - Contract Immune Monitoring and Research
Cellular Technology Limited (CTL), headquartered in Shaker Heights, OH, is a privately held biotechnology company that built its reputation as the global leader in the ELISPOT field over the past two decades by establishing the ELISPOT instrumentation and scientific principles that have helped to define the parameters of ELISPOT research for monitoring of Cell-Mediated Immunity.... Contract Research & Services > Clinical Trials > Suppliers
WeylChem Group of Companies. Better chemistry – achieving more.
WeylChem Group of Companies (WCGC) was established in 2005 as the Fine Chemicals platform of International Chemical Investors Group (ICIG), a privately owned industrial holding company. We are a specialised service provider to the agrochemical, pharmaceutical, polymer and specialty chemicals industries, offering custom-, toll-manufacturing as well as advanced intermediates, reagents and performance products.... Production & Manufacturing > Fine & Speciality Chemicals > Suppliers
See more

PBR White Paper Recommendations

Cellular Technology Limited: A multicolor Natural Killer cell-mediated cytotoxicity detection By CTL Laboratories
A multicolor Natural Killer cell-mediated cytotoxicity detection using fluorescence and direct cell imaging.... Contract Research & Services > Clinical Trials > White Papers Vetter: A unique blend of expertise By Vetter Pharma International
From clinical development to commercial production.... Drug Research > Drug Delivery > White Papers Vetter Development Service - Supporting your compound’s success By Vetter Pharma International
A unique blend of expertise for clinical manufacturing.... Drug Research > Drug Delivery > White Papers Vetter Commercial Manufacturing - Delivering results across the production chain By Vetter Pharma International
A unique blend of capabilities for aseptic fill and finish.... Drug Research > Drug Delivery > White Papers Vetter Packaging Solutions - Delivering your product's potential By Vetter Pharma International
A unique blend of resources for filling and packaging.... Drug Research > Drug Delivery > White Papers See more
1-15 of 55632 results